JuSun/iStock via Getty Images Bright Minds Biosciences (NASDAQ:DRUG) partners with Firefly Neuroscience (NASDAQ:AIFF) to analyze EEG data for mid-stage receptor agonist study, a Phase 2 Trial of BMB-...
Source LinkJuSun/iStock via Getty Images Bright Minds Biosciences (NASDAQ:DRUG) partners with Firefly Neuroscience (NASDAQ:AIFF) to analyze EEG data for mid-stage receptor agonist study, a Phase 2 Trial of BMB-...
Source Link
Comments